{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:48:58Z","timestamp":1780624138648,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10067-021-05658-y","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T19:03:38Z","timestamp":1614193418000},"page":"3195-3205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Real world utilization of the myositis autoantibody panel"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0866-0022","authenticated-orcid":false,"given":"Mithu","family":"Maheswaranathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Johannemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason J.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Jessee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Eudy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Criscione-Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"issue":"3","key":"5658_CR1","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ncl.2014.04.007","volume":"32","author":"MM Dimachkie","year":"2014","unstructured":"Dimachkie MM, Barohn RJ, Amato AA (2014) Idiopathic inflammatory myopathies. Neurol Clin 32(3):595\u2013628 vii","journal-title":"Neurol Clin"},{"issue":"3","key":"5658_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s13317-014-0060-4","volume":"5","author":"A Ghirardello","year":"2014","unstructured":"Ghirardello A, Borella E, Beggio M, Franceschini F, Fredi M, Doria A (2014) Myositis autoantibodies and clinical phenotypes. Auto Immunol Highlights 5(3):69\u201375","journal-title":"Auto Immunol Highlights"},{"issue":"1","key":"5658_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12016-015-8513-8","volume":"52","author":"H Gunawardena","year":"2017","unstructured":"Gunawardena H (2017) The clinical features of myositis-associated autoantibodies: a review. Clin Rev Allergy Immunol 52(1):45\u201357","journal-title":"Clin Rev Allergy Immunol"},{"issue":"8","key":"5658_CR4","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.3899\/jrheum.141443","volume":"42","author":"I Pinal-Fernandez","year":"2015","unstructured":"Pinal-Fernandez I, Casciola-Rosen LA, Christopher-Stine L, Corse AM, Mammen AL (2015) The Prevalence of individual histopathologic features varies according to autoantibody status in muscle biopsies from patients with dermatomyositis. J Rheumatol 42(8):1448\u20131454","journal-title":"J Rheumatol"},{"issue":"1","key":"5658_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/joim.12451","volume":"280","author":"Z Betteridge","year":"2016","unstructured":"Betteridge Z, McHugh N (2016) Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med 280(1):8\u201323","journal-title":"J Intern Med"},{"issue":"6","key":"5658_CR6","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/BOR.0000000000000329","volume":"28","author":"M Fujimoto","year":"2016","unstructured":"Fujimoto M, Watanabe R, Ishitsuka Y, Okiyama N (2016) Recent advances in dermatomyositis-specific autoantibodies. Curr Opin Rheumatol 28(6):636\u2013644","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"5658_CR7","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/rheumatology\/keq153","volume":"49","author":"K Hoshino","year":"2010","unstructured":"Hoshino K, Muro Y, Sugiura K, Tomita Y, Nakashima R, Mimori T (2010) Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis. Rheumatology (Oxford) 49(9):1726\u20131733","journal-title":"Rheumatology (Oxford)"},{"issue":"16","key":"5658_CR8","doi-asserted-by":"publisher","first-page":"26552","DOI":"10.18632\/oncotarget.15716","volume":"8","author":"L Li","year":"2017","unstructured":"Li L, Wang Q, Yang F, Wu C, Chen S, Wen X, Liu C, Li Y (2017) Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis. Oncotarget. 8(16):26552\u201326564","journal-title":"Oncotarget."},{"issue":"11","key":"5658_CR9","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2169\/internalmedicine.56.7956","volume":"56","author":"K Tokunaga","year":"2017","unstructured":"Tokunaga K, Hagino N (2017) Dermatomyositis with rapidly progressive interstitial lung disease treated with rituximab: a report of 3 cases in Japan. Intern Med 56(11):1399\u20131403","journal-title":"Intern Med"},{"issue":"1","key":"5658_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","volume":"52","author":"M Satoh","year":"2017","unstructured":"Satoh M, Tanaka S, Ceribelli A, Calise SJ, Chan EK (2017) A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol 52(1):1\u201319","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"5658_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13317-011-0018-8","volume":"2","author":"SH van Dooren","year":"2011","unstructured":"van Dooren SH, van Venrooij WJ, Pruijn GJ (2011) Myositis-specific autoantibodies: detection and clinical associations. Auto Immunol Highlights 2(1):5\u201320","journal-title":"Auto Immunol Highlights"},{"issue":"1","key":"5658_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13075-017-1469-8","volume":"19","author":"H Yang","year":"2017","unstructured":"Yang H, Peng Q, Yin L, Li S, Shi J, Zhang Y, Lu X, Shu X, Zhang S, Wang G (2017) Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study. Arthritis Res Ther 19(1):259","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"5658_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120313","volume":"10","author":"H Hozumi","year":"2015","unstructured":"Hozumi H, Enomoto N, Kono M, Fujisawa T, Inui N, Nakamura Y, Sumikawa H, Johkoh T, Nakashima R, Imura Y, Mimori T, Suda T (2015) Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis\/dermatomyositis-associated interstitial lung disease: a retrospective case control study. PLoS One 10(3):e0120313","journal-title":"PLoS One"},{"key":"5658_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2016.02.017","volume":"433","author":"I Cavazzana","year":"2016","unstructured":"Cavazzana I, Fredi M, Ceribelli A, Mordenti C, Ferrari F, Carabellese N, Tincani A, Satoh M, Franceschini F (2016) Testing for myositis specific autoantibodies: comparison between line blot and immunoprecipitation assays in 57 myositis sera. J Immunol Methods 433:1\u20135","journal-title":"J Immunol Methods"},{"issue":"4","key":"5658_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11926-018-0726-4","volume":"20","author":"V Leclair","year":"2018","unstructured":"Leclair V, Lundberg IE (2018) New myositis classification criteria-what we have learned since Bohan and Peter. Curr Rheumatol Rep 20(4):18","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"5658_CR16","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, Visser M et al (2017) 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76(12):1955\u20131964","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"5658_CR17","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F, Flaherty KR, Wells A, Martinez FJ, Azuma A, Bice TJ, Bouros D, Brown KK, Collard HR, Duggal A, Galvin L, Inoue Y, Jenkins RG, Johkoh T, Kazerooni EA, Kitaichi M, Knight SL, Mansour G, Nicholson AG, Pipavath SNJ, Buend\u00eda-Rold\u00e1n I, Selman M, Travis WD, Walsh S, Wilson KC, American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society (2018) Diagnosis of idiopathic pulmonary fibrosis. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 198(5):e44\u2013e68","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"5658_CR18","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1136\/ard.2008.093161","volume":"68","author":"S Bernatsky","year":"2009","unstructured":"Bernatsky S, Joseph L, Pineau CA, Belisle P, Boivin JF, Banerjee D, Clarke AE (2009) Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences. Ann Rheum Dis 68(7):1192\u20131196","journal-title":"Ann Rheum Dis"},{"key":"5658_CR19","unstructured":"U.S. Census Bureau (2018). American Community Survey 1-year estimates. Retrieved from Census Reporter Profile page for Raleigh-Durham-Chapel Hill, NC CSA. http:\/\/censusreporter.org\/profiles\/33000US450-raleigh-durham-chapel-hill-nc-csa\/ [Internet]"},{"issue":"1","key":"5658_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/08916930400022681","volume":"38","author":"A Ghirardello","year":"2005","unstructured":"Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Bendo R, Gambari PF et al (2005) Anti-Mi-2 antibodies. Autoimmunity. 38(1):79\u201383","journal-title":"Autoimmunity."},{"issue":"3","key":"5658_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00408-019-00212-9","volume":"197","author":"L Fidler","year":"2019","unstructured":"Fidler L, Doubelt I, Kandel S, Fisher JH, Mittoo S, Shapera S (2019) Screening for myositis antibodies in idiopathic interstitial lung disease. Lung. 197(3):277\u2013284","journal-title":"Lung."},{"issue":"5","key":"5658_CR22","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.pathol.2019.03.007","volume":"51","author":"BR Stevenson","year":"2019","unstructured":"Stevenson BR, Thompson GA, Watson MC, Bundell CS, Klinken EM, John M, Lake FR, McLean-Tooke AP (2019) Autoantibodies in interstitial lung diseases. Pathology. 51(5):518\u2013523","journal-title":"Pathology."},{"issue":"7","key":"5658_CR23","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/resp.13163","volume":"22","author":"JD Prasad","year":"2017","unstructured":"Prasad JD, Mahar A, Bleasel J, Ellis SJ, Chambers DC, Lake F, Hopkins PMA, Corte TJ, Allan H, Glaspole IN (2017) The interstitial lung disease multidisciplinary meeting: a position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia. Respirology. 22(7):1459\u20131472","journal-title":"Respirology."},{"issue":"5","key":"5658_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11926-018-0733-5","volume":"20","author":"PW Wolstencroft","year":"2018","unstructured":"Wolstencroft PW, Fiorentino DF (2018) Dermatomyositis clinical and pathological phenotypes associated with myositis-specific autoantibodies. Curr Rheumatol Rep 20(5):28","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"5658_CR25","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3349\/ymj.2015.56.3.676","volume":"56","author":"JS Song","year":"2015","unstructured":"Song JS, Hwang J, Cha HS, Jeong BH, Suh GY, Chung MP, Kang ES (2015) Significance of myositis autoantibody in patients with idiopathic interstitial lung disease. Yonsei Med J 56(3):676\u2013683","journal-title":"Yonsei Med J"},{"issue":"4","key":"5658_CR26","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1183\/13993003.00150-2015","volume":"46","author":"A Fischer","year":"2015","unstructured":"Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, Lee JS, Leslie KO, Lynch DA, Matteson EL, Mosca M, Noth I, Richeldi L, Strek ME, Swigris JJ, Wells AU, West SG, Collard HR, Cottin V (2015) An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 46(4):976\u2013987","journal-title":"Eur Respir J"},{"issue":"12","key":"5658_CR27","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/art.40679","volume":"70","author":"EM Wilfong","year":"2018","unstructured":"Wilfong EM, Lentz RJ, Guttentag A, Tolle JJ, Johnson JE, Kropski JA, Kendall PL, Blackwell TS, Crofford LJ (2018) Interstitial pneumonia with autoimmune features: an emerging challenge at the intersection of rheumatology and pulmonology. Arthritis Rheum 70(12):1901\u20131913","journal-title":"Arthritis Rheum"},{"key":"5658_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.rmed.2017.03.028","volume":"132","author":"CA Scire","year":"2017","unstructured":"Scire CA, Gonzalez-Gay MA, Selva-O'Callaghan A, Cavagna L (2017) Clinical spectrum time course of interstitial pneumonia with autoimmune features in patients positive for antisynthetase antibodies. Respir Med 132:265\u2013266","journal-title":"Respir Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05658-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05658-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05658-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T20:08:17Z","timestamp":1626725297000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05658-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["5658"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05658-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,24]]},"assertion":[{"value":"16 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was not required for this study (exempt from IRB review).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}